RANTES: a genetic risk marker for multiple sclerosis

Abstract

Regulated upon activation, normal T-cell expressed and secreted (RANTES) is a beta-chemokine and has been detected in brain lesions of multiple sclerosis (MS) patients. Considering its potential role in MS, we screened two functional polymorphisms in the proximal promoter region of the RANTES in MS patients versus controls. Methods: We examined 140 postmortem brain samples from subjects with a primary diagnosis of MS, and peripheral blood samples from 216 control subjects. The RANTES-28C/G and -403G/A promoter polymorphisms were examined. All subjects were non-Hispanic Caucasians. Results: MS cases differed from controls showing a significant association with the 403G/A polymorphism (odds ratio, 2.359, [1.465-3.799]; P-0.0001), but not the -28C/G (P-NS) polymorphism. There was a significant association of the -28G allele with both early onset (P-0.031) and longer survival (P-0.006). Conclusion: There is a significant but complex association of the RANTES gene with MS.

Keywords

central nervous system chemokines cytokines multiple sclerosis RANTES

Get full access to this article

View all access options for this article.

References

Noseworthy JH , Lucchinetti C , Rodriguez M , Weinshenker BG. Multiple sclerosis . N Engl J Med 2000; 343: 938-952 .

Lublin FD , Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis . Neurology 1996; 46: 907-911 .

Sorensen TL , Tani M , Jensen J , Pierce V , Lucchinetti C , Folcik VA et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients . J Clin Invest 1999; 103: 807-815 .

Sun D , Tani M , Newman TA , Krivacic K , Phillips M , Chernosky A et al. Role of chemokines, neuronal projections, and the blood brain barrier in the enhancement of cerebral EAE following focal brain damage . J Neuropathol Exp Neurol 2000; 59: 1031-1043 .

Simpson JE , Newcombe J , Cuzner ML , Woodroofe MN. Expression of monocyte chem-attractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions . J Neuroimmunol 1998; 84: 238-249 .

Palma JP , Kim BS. Induction of selected chemokines in glial cells infected with Theiler’s virus . J Neuroimmunol 2001; 117: 166-170 .

Baranzini SE , Elfstrom C , Chang SY , Butunoi C , Murray R , Higuchi R et al. Transcriptional analysis of multiple sclerosis brain lesions reveal a complex pattern of cytokine expression . J Immunol 2000; 16: 6576-6582 .

Hvas J , McLean C , Justesen J , Kannourakis G , Steinman L , Oksenberg JR et al. Perivascular T cells express pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions . Scand J Immunol 1997; 46: 195-203 .

Barnes DA , Huston M , Holmes R , Benveniste EN , Yong VW , Scholz P et al. Induction of RANTES expression by astrocytes and astrocytoma cell lines . J Neuroimmunol 1996; 71: 207-214 .

10.

Li QQ , Bever CT , Burt DR , Judge SI , Trisler GD. Induction of RANTES chemokine expression in human astrocytic cells is dependent upon activation of NF-kappa B transcription factor . Int J Mol Med 2001; 7: 427-433 .

11.

Li QQ , Bever CT. Comparison of RANTES chemokine induction by Th1 cytokines in human astoglial cell lines . Int J Mol Med 2001; 8: 95-101 .

12.

Kivisakk P , Teleshova N , Ozenci V , Huang Y , Matusevicius D , Fredrikson S et al. No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis . J Neuroimmunol 1998; 91: 108-112 .

13.

Iarlori C , Reale M , Lugaresi A , De Luca G , Bonanni L , Di Iorio A et al. RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b . J Neuroimmunol 2000; 107: 100-107 .

14.

Sindern E , Niederkinkhaus Y , Henschel M , Ossege LM , Patzold T , Malin JP. Differential release of beta-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis . Acta Neurol Scand 2001; 104: 88-91 .

15.

Zang YC , Halder JB , Samanta AK , Hong J , Rivera VM , Zhang JZ. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta . J Neuroimmunol 2001; 112: 174-180 .

16.

Li QQ , Bever CT. Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription . Neurochem Res 2001; 26: 125-133 .

17.

Gade-Andavolu R , Comings DE , MacMurray J , RostamKhani M , Tourttelotte W , Cone LA. CCR5 delta 32 mutation predicts survival in patients with multiple sclerosis . Genet Med 2004; 6: 126-131 .

18.

Donlon TA , Krensky AM , Wallace MR , Collins FS , Lovett M , Clayberger C. Localization of a human T cell specific gene, RANTES (D17s136E) to chromosome 17q11.2-q12 . Genomics 1990; 6: 548-553 .

19.

Liu H , Chao D , Nakayama EE , Taguchi H , Goto M , Xin X et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression . Proc Natl Acad Sci USA 1999; 96: 4581-4585 .

20.

McDermott DH , Beecroft MJ , Kleeberger CA , Al-Sharif FM , Ollier WE , Zimmerman PA et al. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multi-center AIDS Cohort Study . AIDS 2000; 14: 2671-2678 .

21.

Gonzalez E , Dhanda R , Bamshad M , Mummidi S , Geevarghese R , Catano G et al. Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic . Proc Natl Acad Sci USA 2001; 98: 5199-5204 .

22.

Hajeer AH , Al-Sharif F , Ollier WE. A polymorphism at position -403 in the human RANTES promoter . Eur J Immunogenet 1999; 26: 373-374 .

23.

Al-Sharif FM , Ollier WE , Hajeer AH. A rare polymorphism at position -28 in the human RANTES promoter . Eur J Immunogenet 1999; 5: 373-374 .

24.

Midgard R , Albrektsen G , Riise T , Kvale G , Nyland H. Prognostic factors for survival in multiple sclerosis: a long-itudinal, population based study in More and Romsdal, Norway . J Neurol Neurosurg Psychiatry 1995; 58: 417-421 .

25.

Comings DE , Gonzalez NS , Cheng Li S-C , MacMurray J. A ‘line item’ approach to the identification of genes involved in polygenic behavioral disorders: the adrenergic 2A (ADRA2A) gene . Am J Med Genet (Neurospychiatric Genetics) 2003; 118B: 110-114 .